Science Explorer Interactive view Map
Company · Pasadena · United States

O-Ray Pharma (United States)

Research works
4
fractional, all time
Citations
161
43.5 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
73%
world 28%

Not ranked overall: O-Ray Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does O-Ray Pharma (United States) publish most on?

By volume: Hearing, Cochlea, Tinnitus, Genetics, Ear Surgery and Otitis Media, Congenital Ear and Nasal Anomalies and Advanced Aircraft Design and Technologies.

  1. 1 Hearing, Cochlea, Tinnitus, Genetics Sensory Systems 1 works
  2. 2 Ear Surgery and Otitis Media Otorhinolaryngology 0 works
  3. 3 Congenital Ear and Nasal Anomalies Genetics 0 works
  4. 4 Advanced Aircraft Design and Technologies Global and Planetary Change 0 works
  5. 5 Impact of Light on Environment and Health Global and Planetary Change 0 works
  6. 6 Electrohydrodynamics and Fluid Dynamics Electrical and Electronic Engineering 0 works
  7. 7 Microfluidic and Capillary Electrophoresis Applications Biomedical Engineering 0 works
  8. 8 Aerospace and Aviation Technology Aerospace Engineering 0 works
  9. 9 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
  10. 10 Hearing Loss and Rehabilitation Cognitive Neuroscience 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available73.0%not open27.0%

World: 28% of research is openly available.

How has O-Ray Pharma (United States)'s research output changed?

20152020

Other research institutions in Pasadena

All research institutions in Pasadena

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.